Logo image of CG

CARLYLE GROUP INC/THE (CG) Stock Fundamental Analysis

NASDAQ:CG - Nasdaq - US14316J1088 - Common Stock - Currency: USD

40.83  +1.67 (+4.26%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CG. CG was compared to 230 industry peers in the Capital Markets industry. There are concerns on the financial health of CG while its profitability can be described as average. CG is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CG was profitable.
In the past year CG has reported a negative cash flow from operations.
Of the past 5 years CG 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CG reported negative operating cash flow in multiple years.
CG Yearly Net Income VS EBIT VS OCF VS FCFCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

1.2 Ratios

CG has a better Return On Assets (4.42%) than 61.30% of its industry peers.
CG's Return On Equity of 18.20% is amongst the best of the industry. CG outperforms 85.65% of its industry peers.
The Return On Invested Capital of CG (6.50%) is better than 75.65% of its industry peers.
Industry RankSector Rank
ROA 4.42%
ROE 18.2%
ROIC 6.5%
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.72%
ROE(5y)19.09%
ROIC(3y)N/A
ROIC(5y)N/A
CG Yearly ROA, ROE, ROICCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

Looking at the Profit Margin, with a value of 18.81%, CG is in line with its industry, outperforming 56.09% of the companies in the same industry.
CG's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 24.64%, CG is in line with its industry, outperforming 46.09% of the companies in the same industry.
In the last couple of years the Operating Margin of CG has declined.
The Gross Margin of CG (62.27%) is better than 70.00% of its industry peers.
In the last couple of years the Gross Margin of CG has declined.
Industry RankSector Rank
OM 24.64%
PM (TTM) 18.81%
GM 62.27%
OM growth 3Y-18.19%
OM growth 5Y-7.53%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
CG Yearly Profit, Operating, Gross MarginsCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CG has less shares outstanding
The number of shares outstanding for CG has been increased compared to 5 years ago.
The debt/assets ratio for CG has been reduced compared to a year ago.
CG Yearly Shares OutstandingCG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CG Yearly Total Debt VS Total AssetsCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that CG is in the distress zone and has some risk of bankruptcy.
CG's Altman-Z score of 0.83 is in line compared to the rest of the industry. CG outperforms 46.96% of its industry peers.
A Debt/Equity ratio of 1.54 is on the high side and indicates that CG has dependencies on debt financing.
CG's Debt to Equity ratio of 1.54 is on the low side compared to the rest of the industry. CG is outperformed by 73.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACCN/A
WACCN/A
CG Yearly LT Debt VS Equity VS FCFCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.45 indicates that CG may have some problems paying its short term obligations.
CG has a worse Current ratio (0.45) than 77.83% of its industry peers.
CG has a Quick Ratio of 0.45. This is a bad value and indicates that CG is not financially healthy enough and could expect problems in meeting its short term obligations.
CG's Quick ratio of 0.45 is on the low side compared to the rest of the industry. CG is outperformed by 77.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
CG Yearly Current Assets VS Current LiabilitesCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.96% over the past year.
The Earnings Per Share has been growing by 16.58% on average over the past years. This is quite good.
CG shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.50%.
Measured over the past years, CG shows a quite strong growth in Revenue. The Revenue has been growing by 9.95% on average per year.
EPS 1Y (TTM)12.96%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%6.98%
Revenue 1Y (TTM)92.5%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%5.81%

3.2 Future

The Earnings Per Share is expected to grow by 9.56% on average over the next years. This is quite good.
CG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.93% yearly.
EPS Next Y12.09%
EPS Next 2Y13.92%
EPS Next 3Y11.83%
EPS Next 5Y9.56%
Revenue Next Year17.13%
Revenue Next 2Y14.83%
Revenue Next 3Y12.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CG Yearly Revenue VS EstimatesCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CG Yearly EPS VS EstimatesCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CG is valuated reasonably with a Price/Earnings ratio of 11.16.
Based on the Price/Earnings ratio, CG is valued a bit cheaper than the industry average as 65.22% of the companies are valued more expensively.
CG is valuated cheaply when we compare the Price/Earnings ratio to 27.75, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.95, the valuation of CG can be described as reasonable.
Based on the Price/Forward Earnings ratio, CG is valued a bit cheaper than the industry average as 67.83% of the companies are valued more expensively.
CG is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.16
Fwd PE 9.95
CG Price Earnings VS Forward Price EarningsCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CG is valued cheaply inside the industry as 80.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.83
CG Per share dataCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.92
PEG (5Y)0.67
EPS Next 2Y13.92%
EPS Next 3Y11.83%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.62%, CG has a reasonable but not impressive dividend return.
In the last 3 months the price of CG has falen by -30.27%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
CG's Dividend Yield is comparable with the industry average which is at 8.35.
CG's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

The dividend of CG decreases each year by -1.73%.
CG has paid a dividend for at least 10 years, which is a reliable track record.
CG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-1.73%
Div Incr Years3
Div Non Decr Years4
CG Yearly Dividends per shareCG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

CG pays out 49.29% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP49.29%
EPS Next 2Y13.92%
EPS Next 3Y11.83%
CG Yearly Income VS Free CF VS DividendCG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B
CG Dividend Payout.CG Dividend Payout, showing the Payout Ratio.CG Dividend Payout.PayoutRetained Earnings

More info and screens

CARLYLE GROUP INC/THE

NASDAQ:CG (5/2/2025, 3:43:00 PM)

40.83

+1.67 (+4.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-11 2025-02-11/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners61.35%
Inst Owner Change0.27%
Ins Owners26.62%
Ins Owner Change-2.06%
Market Cap14.73B
Analysts71.85
Price Target50.75 (24.3%)
Short Float %4.03%
Short Ratio2.9
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly Dividend1.4
Dividend Growth(5Y)-1.73%
DP49.29%
Div Incr Years3
Div Non Decr Years4
Ex-Date02-21 2025-02-21 (0.35)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-6.9%
Max EPS beat(2)1.19%
EPS beat(4)2
Avg EPS beat(4)-2.52%
Min EPS beat(4)-8.37%
Max EPS beat(4)3.99%
EPS beat(8)5
Avg EPS beat(8)3.95%
EPS beat(12)8
Avg EPS beat(12)3.28%
EPS beat(16)12
Avg EPS beat(16)12.38%
Revenue beat(2)0
Avg Revenue beat(2)-7.14%
Min Revenue beat(2)-9.92%
Max Revenue beat(2)-4.35%
Revenue beat(4)0
Avg Revenue beat(4)-5.43%
Min Revenue beat(4)-9.92%
Max Revenue beat(4)0%
Revenue beat(8)2
Avg Revenue beat(8)-2.14%
Revenue beat(12)3
Avg Revenue beat(12)-1.46%
Revenue beat(16)7
Avg Revenue beat(16)43.2%
PT rev (1m)-12.98%
PT rev (3m)-12.04%
EPS NQ rev (1m)-1.3%
EPS NQ rev (3m)-9.59%
EPS NY rev (1m)-5.07%
EPS NY rev (3m)-10.12%
Revenue NQ rev (1m)1.2%
Revenue NQ rev (3m)-9.23%
Revenue NY rev (1m)-1.85%
Revenue NY rev (3m)-6.46%
Valuation
Industry RankSector Rank
PE 11.16
Fwd PE 9.95
P/S 2.72
P/FCF N/A
P/OCF N/A
P/B 2.63
P/tB 2.96
EV/EBITDA 13.83
EPS(TTM)3.66
EY8.96%
EPS(NY)4.1
Fwd EY10.05%
FCF(TTM)-2.32
FCFYN/A
OCF(TTM)-2.1
OCFYN/A
SpS15.03
BVpS15.54
TBVpS13.78
PEG (NY)0.92
PEG (5Y)0.67
Profitability
Industry RankSector Rank
ROA 4.42%
ROE 18.2%
ROCE 8.31%
ROIC 6.5%
ROICexc 7.48%
ROICexgc 16.58%
OM 24.64%
PM (TTM) 18.81%
GM 62.27%
FCFM N/A
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.72%
ROE(5y)19.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-39.75%
ROICexcg growth 5Y-2.37%
ROICexc growth 3Y-33.35%
ROICexc growth 5Y-6.78%
OM growth 3Y-18.19%
OM growth 5Y-7.53%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
F-Score7
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 5.66
Cap/Depr 42.21%
Cap/Sales 1.43%
Interest Coverage 14.29
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z 0.83
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)175.39%
Cap/Depr(5y)144.65%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.96%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%6.98%
EPS Next Y12.09%
EPS Next 2Y13.92%
EPS Next 3Y11.83%
EPS Next 5Y9.56%
Revenue 1Y (TTM)92.5%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%5.81%
Revenue Next Year17.13%
Revenue Next 2Y14.83%
Revenue Next 3Y12.93%
Revenue Next 5YN/A
EBIT growth 1Y280.91%
EBIT growth 3Y-30.32%
EBIT growth 5Y1.66%
EBIT Next Year14.57%
EBIT Next 3Y18.49%
EBIT Next 5Y10.09%
FCF growth 1Y-705.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-470.67%
OCF growth 3YN/A
OCF growth 5YN/A